Moderna COVID-19 Vaccine (2024-2025 Formula) FACT SHEET FOR RECIPIENTS FACT SHEET FOR PROVIDERS LETTER OF AUTHORIZATION How can we help you? Report a side effect Online: Moderna's Adverse Event Intake Portal or U.S. HHS's Vaccine Adverse Event Reporting System Connect with us Email: We...
Spikevax(COVID-19 Vaccine, mRNA) isapprovedfor use in individuals 12 years of age and older. Moderna COVID-19 Vaccineisauthorizedunder an Emergency Use Authorization (EUA)in individuals 6 months through 11 years of age. The EUA for this product is in effect for the duration of the COVID-...
SPIKEVAX（COVID-19 疫苗，mRNA）是一款经FDA批准的 COVID-19 疫苗，由 ModernaTX 公司生产。它获批准为两剂系列，用于 18 岁及以上的人群预防 COVID-19。它还获 EUA 授权用于为以下人群提供：•为 12 岁至 17 岁的个人提供两剂基础系列；以及 •为 12 岁及以上被确定为有某种免疫功能低下的个人提供...
For more information visitCOVID-19 immunization - Province of British Columbia (gov.bc.ca) **Walk-in requests may be accommodated subject to availability ** COVID-19 Vaccine mRNA Formulations (subject to availability) Moderna Spikevax KP.2 ...
Moderna's new version of its COVID-19 vaccine, which targets two virus variants including Omicron, has outperformed the company's original Spikevax shot in a head-to-head clinical trial. mRNA-1273.214 stimulated almost twice the neutralising antibody lev
FullText To more closely target SARS-CoV-2 variants currently circulating in the US, the US Food and Drug Administration (FDA) authorized an updated formula of the messenger RNA (mRNA) COVID-19 vaccine, the agencyannouncedin mid-August. ...
COVID-19疫苗与AEI发生率的小幅下降相关。无论是接种Comirnaty疫苗、Vaxzevria疫苗,还是第二剂Spikevax疫苗,AEI发生率都没有增加。 研究背景和目的 截至2022年12月,英国使用的疫苗包括Comirnaty(BNT162b2mRNA,BioNTechPfizer)Vaxzevria(ChAdOx1-S,Oxford-AstraZeneca)和Spikevax(mRNA-1273, Moderna)。COVID-19疫...
Before receiving the Moderna COVID-19 vaccine You should not receive the Moderna COVID-19 vaccine if you have had: a severe allergic reaction to a previous dose of the Moderna COVID-19 vaccine, Spikevax, or any of the components of the vaccine (seeIngredientsbelow). ...
Approval of Spikevax (COVID-19 Vaccine, mRNA) to include the 2023-2024 formula, a change to a single dose for individuals 18 years of age and older, and approval of a single dose for individuals 12 through 17 years of age. Spikevax was previously ...
The approval of Spikevax (COVID-19 Vaccine, mRNA) (2024-2025 Formula) was granted to Moderna and the EUA amendment for the Moderna COVID-19 Vaccine (2024-2025 Formula) was issued to Moderna. vaccine finderwhich people can use to identify nearby vaccination locations. ...